Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Plus, nearly a third of people already taking Truvada for PrEP switched to the new combination pill.
An East Harlem HIV prevention campaign focuses on Black and Latino New Yorkers at higher risk.
However, all integrase inhibitors were associated with similar weight gain.
The Rapid Start and PrEP program in Oklahoma is part of the federal “Ending the HIV Epidemic” initiative.
People whose viral load rebounds on Tivicay may not need to switch medications.
Basic science may suggest it, but more studies still need to be done.
An HIV prevention roundup
Enrollees in the national Ready, Set, PrEP program can now have their meds delivered via mail at no cost.
The U.S. government and HIV drugmaker Gilead Sciences continue to fight over patents for Truvada and Descovy as PrEP.
PrEPception, breast feeding and HIV trial participation are front and center in updated federal guidelines.
“All insurers failing to offer PrEP without cost sharing beginning in January 2021 are clearly not following the law.”
A new PrEP telehealth system at Stanford Children’s Health offers HIV prevention to youth and adults 25 and younger.
At a recent conference, a leading infectious disease provider in New York City advocated this as a means of improving patient satisfaction.
Long-acting injectable cabotegravir for HIV prevention could hit the market for men and women in early 2022.
This may reflect loss of the weight-suppressing effect of the older version of the drug.
Studies of the link between tenofovir use and coronavirus infection or COVID-19 outcomes have yielded mixed results.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.